MMH
AZN icon

Menora Mivtachim Holdings’s AstraZeneca AZN Stock Holding History

Menora Mivtachim Holdings’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,940
Closed -$215K – 78
2016
Q4 		$215K Buy
+3,940
New +$224K 0.01% 77

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Menora Mivtachim Holdings's AZN Position: Q1 2017 in Review

Menora Mivtachim Holdings sold out of AstraZeneca (AZN) in Q1 2017, closing a stake of 3,940 shares — an estimated $215K sold.

Menora Mivtachim Holdings first reported a position in AZN in Q4 2016 and held it in 1 quarter. The position peaked at $215K in Q4 2016. 461 funds tracked by Wall St. Rank hold AZN as of Q1 2017.

  • Menora Mivtachim Holdings reported no remaining AstraZeneca position as of Q1 2017 after selling out during the quarter.
  • Menora Mivtachim Holdings sold 3,940 AstraZeneca shares in Q1 2017, an estimated $215K.
  • Menora Mivtachim Holdings first reported a position in AstraZeneca in Q4 2016 and held it in 1 quarter.
  • Menora Mivtachim Holdings's AstraZeneca position peaked at $215K in Q4 2016.
  • 461 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2017.

Based on Menora Mivtachim Holdings's 13F filing for Q1 2017, filed 9 May 2017.